TrialClinical pharmacokinetics2025

Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma.

Yuwen Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.